Article Information
- Received December 20, 1999
- Revision received February 23, 2000
- Accepted March 6, 2000
- First published June 1, 2000.
- Version of record published June 1, 2000.
Author Information
Author contributions
Disclosures
- Received December 20, 1999.
- Revision received February 23, 2000.
- Accepted March 6, 2000.
We thank Marie-Claire Pflimlin, Urs Humbel, Veronique Graf, Birgit Molitor, Danièle Buchy, Marie-Laurence Harlé-Ygé, Yolande Lang, and Jürg Messer for expert technical assistance. We also thank Dr. Guy Higgins for helpful discussion of this manuscript.
J.N.C.K. and A.K. contributed equally to this work.
Correspondence should be addressed to James N. C. Kew, Pharma Division, Preclinical CNS Research, F. Hoffmann-La Roche Ltd., Building 70/343, CH-4070 Basel, Switzerland. E-mail:james_n.kew{at}roche.com.
Dr. Koester's present address: Eli Lilly, Lilly Corporate Center DC 0444, Indianapolis, IN 46285.
Dr. Reinscheid's present address: Department of Pharmacology, College of Medicine, 354 Med Surge II, University of California Irvine, Irvine, CA 92697-4625.
Online Impact